₹2,437.6
▲ +25.33 +1.05%
17 Jul 2026
NSE Listed · Pharmaceuticals
Hester Biosciences Ltd. (HESTERBIO)
Volume: 31,791Avg Vol 1W: 32,030Avg Vol 1M: 45,54452W Range:₹1,239.3₹2,660
Key Ratios
Checked just nowMarket Cap₹2,074 Cr
Current Price₹2,437.6
Previous Close₹2,412.27
High / Low (52w)₹2,660 / ₹1,239.3
Volume31,791
Avg Vol (1W)32,030
Avg Vol (1M)45,544
Stock P/E125.33
Book Value₹423.46
Dividend Yield45%
ROE15.45%
ROA8.48%
Revenue (TTM)—
Revenue Growth2.15%
Profit Margin16.73%
Total Debt₹133 Cr
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹62.97
P/B5.76
Debt / Equity0.54
50 DMA₹2,173.38
200 DMA₹1,753.84
Day change+1.05%
Price Chart
₹2,437.6▲ 49.91% · 1Y
2025-11-242026-07-16
20-day avg volume: 50K shares
Pros
- Healthy return on equity of 15.4%.
- Pays a dividend yield of 45.0%.
- Company is almost debt-free.
- Net profit is growing year over year.
Cons
- Stock trades at a high P/E of 125.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹82 Cr | ₹84 Cr | ₹63 Cr | ₹82 Cr | ₹84 Cr | ₹71 Cr | ₹77 Cr | ₹100 Cr |
| EBITDA | ₹15 Cr | ₹17 Cr | ₹9 Cr | ₹8 Cr | ₹21 Cr | ₹17 Cr | ₹14 Cr | ₹25 Cr |
| Net Profit | ₹6 Cr | ₹8 Cr | ₹12 Cr | ₹1 Cr | ₹16 Cr | ₹14 Cr | ₹9 Cr | ₹16 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹185 Cr | ₹190 Cr | ₹219 Cr | ₹249 Cr | ₹281 Cr | ₹315 Cr | ₹315 Cr | ₹342 Cr |
| EBITDA | ₹63 Cr | ₹49 Cr | ₹60 Cr | ₹57 Cr | ₹45 Cr | ₹47 Cr | ₹48 Cr | ₹77 Cr |
| Net Profit | ₹42 Cr | ₹29 Cr | ₹34 Cr | ₹39 Cr | ₹27 Cr | ₹19 Cr | ₹27 Cr | ₹56 Cr |
| EPS | 48.86 | 36.44 | 40.79 | 46.41 | 31.3 | 24.88 | 33.89 | 67.57 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹299 Cr | ₹387 Cr | ₹411 Cr | ₹562 Cr | ₹670 Cr | ₹662 Cr | ₹653 Cr | ₹678 Cr |
| Total Liabilities | ₹118 Cr | ₹180 Cr | ₹175 Cr | ₹295 Cr | ₹381 Cr | ₹359 Cr | ₹327 Cr | ₹310 Cr |
| Equity | ₹181 Cr | ₹206 Cr | ₹236 Cr | ₹267 Cr | ₹289 Cr | ₹303 Cr | ₹327 Cr | ₹368 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹64 Cr | ₹48 Cr | ₹72 Cr | ₹26 Cr | ₹32 Cr | ₹60 Cr | ₹76 Cr | ₹78 Cr |
| Investing | ₹-23 Cr | ₹-74 Cr | ₹-38 Cr | ₹-117 Cr | ₹-77 Cr | ₹-23 Cr | ₹-19 Cr | ₹-3 Cr |
| Financing | ₹3 Cr | ₹19 Cr | ₹-18 Cr | ₹112 Cr | ₹42 Cr | ₹-26 Cr | ₹-52 Cr | ₹-49 Cr |
| Free Cash Flow | ₹41 Cr | ₹-26 Cr | ₹31 Cr | ₹-70 Cr | ₹-46 Cr | ₹35 Cr | ₹55 Cr | ₹60 Cr |
Shareholding
Promoter 53.73% Institutions 0.38% Public 45.89%
Efficiency & Working Capital
ROCE14.3%
Interest Coverage7.9
Dividend Payout—
Debtor Days105 d
Inventory Days80 d
Payable Days27 d
Cash Conversion Cycle157 d
Working Capital Days184 d
Shareholding Details
As of 2026-03-31
Promoter53.7%
FII0.4%
DII0%
Institutions0.4%
Public45.9%
Promoter Pledge0%
No. of Shareholders12,373
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% |
| FIIs | 0.4% | 0.4% | 0.4% | 0.4% | 0.5% | 0.6% | 0.6% | 0.9% | 0.5% | 0.5% | 0.5% | 0.4% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 45.8% | 45.8% | 45.8% | 45.8% | 45.7% | 45.6% | 45.7% | 45.4% | 45.7% | 45.7% | 45.7% | 45.9% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 12,984 | 13,342 | 13,450 | 12,844 | 11,305 | 11,538 | 11,473 | 11,853 | 11,810 | 12,260 | 12,603 | 12,373 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Rajiv Dinesh Gandhi | Shareholding of Promoter and Promoter Group | 10.5% | 8,91,508 |
| Sanjiv Dinesh Gandhi | Shareholding of Promoter and Promoter Group | 8.2% | 6,97,820 |
| Nina Rajiv Gandhi | Shareholding of Promoter and Promoter Group | 8.2% | 6,96,340 |
| Shaila Bhupendra Gandhi | Shareholding of Promoter and Promoter Group | 5.8% | 4,91,300 |
| Ravin Gandhi | Shareholding of Promoter and Promoter Group | 4.7% | 4,03,320 |
| Bela Gandhi | Shareholding of Promoter and Promoter Group | 4.7% | 4,00,635 |
| Bhupendra Vithaldas Gandhi | Shareholding of Promoter and Promoter Group | 4.7% | 3,97,989 |
| Kuntal Hasmukhlal Shah | Public Shareholding | 3.2% | 2,69,897 |
| Biolink Healthcare Limited | Shareholding of Promoter and Promoter Group | 2.9% | 2,48,838 |
| Manish Jain | Public Shareholding | 2.9% | 2,45,248 |
| Anup Chandravadan Kapadia | Shareholding of Promoter and Promoter Group | 2.7% | 2,28,354 |
| Darshna Dinesh Kapadia | Public Shareholding | 1.8% | 1,53,600 |
| Sandeep Shantilal Gala | Public Shareholding | 1.3% | 1,10,942 |
| Vinay Shah | Public Shareholding | 1.3% | 1,08,900 |
| Manish Jain (huf) | Public Shareholding | 1.2% | 1,04,869 |
| Jagrut Prataprai Gandhi | Public Shareholding | 1.2% | 1,00,000 |
| Manish Prataprai Gandhi | Public Shareholding | 1.2% | 1,00,000 |
| Hester Coatings Llp | Shareholding of Promoter and Promoter Group | 0.8% | 64,000 |
| Hester Diagnostics Private Limited | Shareholding of Promoter and Promoter Group | 0.3% | 24,000 |
| Hetal Sanjiv Gandhi | Shareholding of Promoter and Promoter Group | 0.2% | 19,590 |
| Yash Rajiv Gandhi | Shareholding of Promoter and Promoter Group | 0.1% | 7,250 |
| Bhupendra Vithaldas Gandhi Huf | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Rajiv Dinesh Gandhi | 0 | 0% | 2026-03-31 |
| Nina Rajiv Gandhi | 0 | 0% | 2026-03-31 |
| Sanjiv Dinesh Gandhi | 0 | 0% | 2026-03-31 |
| Bhupendra Vithaldas Gandhi | 0 | 0% | 2026-03-31 |
| Shaila Bhupendra Gandhi | 0 | 0% | 2026-03-31 |
| Anup Chandravadan Kapadia | 0 | 0% | 2026-03-31 |
| Hetal Sanjiv Gandhi | 0 | 0% | 2026-03-31 |
| Yash Rajiv Gandhi | 0 | 0% | 2026-03-31 |
| Bhupendra Vithaldas Gandhi Huf | 0 | 0% | 2026-03-31 |
| Hester Coatings Llp | 0 | 0% | 2026-03-31 |
| Biolink Healthcare Limited | 0 | 0% | 2026-03-31 |
| Hester Diagnostics Private Limited | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Bhupendra V Gandhi | Chairman & Non Executive Dir. | 2026 |
| Rajiv D Gandhi | ED / MD / CEO / Promoter | 2026 |
| PRIYA RAJIV GANDHI | Executive Director | 2026 |
| Sanjiv D Gandhi | Non Executive Director | 2026 |
| Sandhya Patel | Independent Non Exe. Director | 2026 |
| Ashok Bhadakal | Independent Non Exe. Director | 2026 |
| Ameet Desai | Independent Non Exe. Director | 2026 |
| Anil Jain | Independent Non Exe. Director | 2026 |
| Jatin Yagneshbhai Trivedi | Independent Non Exe. Director | 2026 |
| Vinod Mali | Company Sec. & Compli. Officer | 2026 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Poultry Healthcare | ₹167 Cr | 58.2% |
| Animal Healthcare | ₹120 Cr | 41.8% |
| Others | ₹0 Cr | 0% |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| In India | ₹260 Cr | 90.9% |
| Outside India | ₹26 Cr | 9.1% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 11 | 9 | 9 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-14 | Dividend (11/- per share) | Final |
| dividend | 2026-07-14 | ₹11 (110%) | Final |
| dividend | 2025-08-06 | ₹7 (70%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 34 | 0 | 0 | 7 | 3 | 44 |
| 2026 | 25 | 0 | 0 | 7 | 3 | 34 |
| 2026 | 9 | 0 | 0 | 0 | 0 | 9 |
Insider / Designated-Person Trades
4 recent disclosure(s)
RAJIV DINESH GANDHIAcquisition · 1,111
BHUPENDRA VITHALDAS GANDHIDisposal · 1,111
SHAILA BHUPENDRA GANDHIAcquisition · 3,01,600
BHUPENDRA VITHALDAS GANDHI HUFDisposal · 3,01,600
Substantial Acquisitions (SAST)
1 disclosure(s)
Market29/01/2024 · 10,000
Company Information
Incorporated1987
ChairmanBhupendra V Gandhi
AuditorChandulal M Shah & Co
Investor Email[email protected]
📍 1st Flr PushpakPachvati Circle, Motilal Hirabhai Road, Ahmedabad, Gujarat, 380006
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search